vs
Side-by-side financial comparison of JBT Marel Corp (JBTM) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $1.0B, roughly 1.1× JBT Marel Corp). JBT Marel Corp runs the higher net margin — 5.3% vs -127.8%, a 133.1% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $83.5M). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 1.3%).
JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
JBTM vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.1B |
| Net Profit | $53.1M | $-1.4B |
| Gross Margin | 34.5% | 32.6% |
| Operating Margin | 7.2% | -116.0% |
| Net Margin | 5.3% | -127.8% |
| Revenue YoY | 115.6% | -2.5% |
| Net Profit YoY | 858.6% | -3093.9% |
| EPS (diluted) | $1.04 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $1.1B | ||
| Q3 25 | $1.0B | $1.0B | ||
| Q2 25 | $934.8M | $1.1B | ||
| Q1 25 | $854.1M | $1.0B | ||
| Q4 24 | $467.6M | $1.1B | ||
| Q3 24 | $453.8M | $1.1B | ||
| Q2 24 | $402.3M | $1.1B | ||
| Q1 24 | $392.3M | $1.1B |
| Q4 25 | $53.1M | $-1.4B | ||
| Q3 25 | $66.0M | $7.5M | ||
| Q2 25 | $3.4M | $-8.4M | ||
| Q1 25 | $-173.0M | $-6.4M | ||
| Q4 24 | $-7.0M | $-44.4M | ||
| Q3 24 | $38.9M | $-21.0M | ||
| Q2 24 | $30.7M | $-108.4M | ||
| Q1 24 | $22.8M | $2.0M |
| Q4 25 | 34.5% | 32.6% | ||
| Q3 25 | 35.9% | 36.1% | ||
| Q2 25 | 35.8% | 34.4% | ||
| Q1 25 | 34.2% | 37.6% | ||
| Q4 24 | 38.4% | 33.9% | ||
| Q3 24 | 36.1% | 37.2% | ||
| Q2 24 | 35.6% | 37.0% | ||
| Q1 24 | 35.8% | 33.1% |
| Q4 25 | 7.2% | -116.0% | ||
| Q3 25 | 10.2% | 7.0% | ||
| Q2 25 | 5.2% | 4.3% | ||
| Q1 25 | -3.9% | 4.5% | ||
| Q4 24 | 3.4% | 10.0% | ||
| Q3 24 | 10.3% | 7.4% | ||
| Q2 24 | 6.7% | -2.5% | ||
| Q1 24 | 7.4% | -5.1% |
| Q4 25 | 5.3% | -127.8% | ||
| Q3 25 | 6.6% | 0.7% | ||
| Q2 25 | 0.4% | -0.8% | ||
| Q1 25 | -20.3% | -0.6% | ||
| Q4 24 | -1.5% | -3.9% | ||
| Q3 24 | 8.6% | -1.9% | ||
| Q2 24 | 7.6% | -10.2% | ||
| Q1 24 | 5.8% | 0.2% |
| Q4 25 | $1.04 | $-10.23 | ||
| Q3 25 | $1.26 | $0.05 | ||
| Q2 25 | $0.07 | $-0.06 | ||
| Q1 25 | $-3.35 | $-0.05 | ||
| Q4 24 | $-0.22 | $-0.32 | ||
| Q3 24 | $1.21 | $-0.15 | ||
| Q2 24 | $0.95 | $-0.79 | ||
| Q1 24 | $0.71 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | — |
| Total DebtLower is stronger | $1.5B | — |
| Stockholders' EquityBook value | $4.5B | $2.9B |
| Total Assets | $8.2B | $8.5B |
| Debt / EquityLower = less leverage | 0.33× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | — | ||
| Q3 25 | — | $432.1M | ||
| Q2 25 | — | $454.2M | ||
| Q1 25 | — | $409.9M | ||
| Q4 24 | $1.2B | $558.8M | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $542.8M | ||
| Q1 24 | — | $658.5M |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $648.3M | — | ||
| Q2 24 | $647.7M | — | ||
| Q1 24 | $647.0M | — |
| Q4 25 | $4.5B | $2.9B | ||
| Q3 25 | $4.4B | $4.4B | ||
| Q2 25 | $4.4B | $4.5B | ||
| Q1 25 | $4.1B | $4.4B | ||
| Q4 24 | $1.5B | $4.3B | ||
| Q3 24 | $1.6B | $4.6B | ||
| Q2 24 | $1.5B | $4.5B | ||
| Q1 24 | $1.5B | $4.7B |
| Q4 25 | $8.2B | $8.5B | ||
| Q3 25 | $8.2B | $10.1B | ||
| Q2 25 | $8.3B | $10.1B | ||
| Q1 25 | $8.0B | $9.8B | ||
| Q4 24 | $3.4B | $9.6B | ||
| Q3 24 | $2.8B | $11.2B | ||
| Q2 24 | $2.7B | $10.4B | ||
| Q1 24 | $2.7B | $10.6B |
| Q4 25 | 0.33× | — | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.81× | — | ||
| Q3 24 | 0.41× | — | ||
| Q2 24 | 0.43× | — | ||
| Q1 24 | 0.43× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $117.4M | $175.4M |
| Free Cash FlowOCF − Capex | $83.5M | $148.6M |
| FCF MarginFCF / Revenue | 8.3% | 13.4% |
| Capex IntensityCapex / Revenue | 3.4% | 2.4% |
| Cash ConversionOCF / Net Profit | 2.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $238.1M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $117.4M | $175.4M | ||
| Q3 25 | $87.7M | $51.7M | ||
| Q2 25 | $102.2M | $75.9M | ||
| Q1 25 | $34.4M | $-64.5M | ||
| Q4 24 | $128.7M | $312.6M | ||
| Q3 24 | $71.9M | $42.2M | ||
| Q2 24 | $21.6M | $9.5M | ||
| Q1 24 | $10.4M | $-1.4M |
| Q4 25 | $83.5M | $148.6M | ||
| Q3 25 | $56.5M | $29.8M | ||
| Q2 25 | $83.7M | $56.7M | ||
| Q1 25 | $14.4M | $-90.0M | ||
| Q4 24 | $118.7M | $274.9M | ||
| Q3 24 | $65.0M | $15.1M | ||
| Q2 24 | $11.1M | $-18.9M | ||
| Q1 24 | $-100.0K | $-26.5M |
| Q4 25 | 8.3% | 13.4% | ||
| Q3 25 | 5.6% | 2.9% | ||
| Q2 25 | 9.0% | 5.4% | ||
| Q1 25 | 1.7% | -8.6% | ||
| Q4 24 | 25.4% | 24.2% | ||
| Q3 24 | 14.3% | 1.4% | ||
| Q2 24 | 2.8% | -1.8% | ||
| Q1 24 | -0.0% | -2.4% |
| Q4 25 | 3.4% | 2.4% | ||
| Q3 25 | 3.1% | 2.1% | ||
| Q2 25 | 2.0% | 1.8% | ||
| Q1 25 | 2.3% | 2.4% | ||
| Q4 24 | 2.1% | 3.3% | ||
| Q3 24 | 1.5% | 2.5% | ||
| Q2 24 | 2.6% | 2.7% | ||
| Q1 24 | 2.7% | 2.3% |
| Q4 25 | 2.21× | — | ||
| Q3 25 | 1.33× | 6.89× | ||
| Q2 25 | 30.06× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 0.70× | — | ||
| Q1 24 | 0.46× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JBTM
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
